Sanofi (SNYN) Stock Statistics & Valuation Metrics
Total Valuation
Sanofi has a market cap or net worth of MXN 2.01T. The enterprise value is MXN 122.96B.
- Market Cap
- MXN 2.01T
- Enterprise Value
- MXN 122.96B
Share Statistics
Sanofi has 2,415,546,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,415,546,900
- Owned by Insiders
- ―
- Owned by Institutions
- 2.28%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.70%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 7.70%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 610.72K
- Profits Per Employee
- 102.14K
- Employee Count
- 76,493
- Asset Turnover
- 0.37
- Inventory Turnover
- 1.28
Valuation Ratios
The current PE Ratio of Sanofi is 24.39. Sanofi’s PEG ratio is -0.43.
- PE Ratio
- 24.39
- PS Ratio
- 1.95
- PB Ratio
- 1.38
- Price to FCF
- 5.80
- Price to Operating Cash Flow
- 5.52
- PEG Ratio
- -0.43
Income Statement
In the last 12 months, Sanofi had revenue of 46.72B and earned 7.81B in profits. Earnings per share was 3.20.
- Revenue
- 46.72B
- Gross Profit
- 33.67B
- Operating Income
- 9.60B
- Pretax Income
- 6.02B
- Net Income
- 7.81B
- EBITDA
- 12.48B
- Earnings Per Share (EPS)
- 3.20
Cash Flow
In the last 12 months, operating cash flow was 14.29B and capital expenditures -2.52B, giving a free cash flow of 11.77B billion.
- Operating Cash Flow
- 14.29B
- Free Cash Flow
- 11.77B
- Free Cash Flow per Share
- 6.89
Dividends & Yields
Sanofi pays an annual dividend of ―, resulting in a dividend yield of 5.52%
- Dividend Per Share
- ―
- Dividend Yield
- 5.52%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 17.25%
- Earnings Yield
- 4.15%
Stock Price Statistics
- Beta
- 0.12
- 52-Week Price Change
- -13.85%
- 50-Day Moving Average
- 746.35
- 200-Day Moving Average
- 764.22
- Relative Strength Index (RSI)
- 77.79
- Average Volume (3m)
- 241
Important Dates
Sanofi upcoming earnings date is Jan 28, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Jan 28, 2027
- Ex-Dividend Date
- ―
Financial Position
Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 28.48%
- Current Ratio
- 1.09
- Quick Ratio
- 0.73
- Debt to Market Cap
- 0.18
- Net Debt to EBITDA
- 1.02
- Interest Coverage Ratio
- 15.33
Taxes
In the past 12 months, Sanofi has paid 1.04B in taxes.
- Income Tax
- 1.04B
- Effective Tax Rate
- 0.17
Enterprise Valuation
Sanofi EV to EBITDA ratio is 8.07, with an EV/FCF ratio of 6.84.
- EV to Sales
- 2.31
- EV to EBITDA
- 8.07
- EV to Free Cash Flow
- 6.84
- EV to Operating Cash Flow
- 6.53
Balance Sheet
Sanofi has MXN 6.35B in cash and marketable securities with MXN 23.58B in debt, giving a net cash position of -MXN 17.23B billion.
- Cash & Marketable Securities
- MXN 6.35B
- Total Debt
- MXN 23.58B
- Net Cash
- -MXN 17.23B
- Net Cash Per Share
- -MXN 7.13
- Tangible Book Value Per Share
- MXN 0.52
Margins
Gross margin is 72.77%, with operating margin of 20.58%, and net profit margin of 8.09%.
- Gross Margin
- 72.77%
- Operating Margin
- 20.58%
- Pretax Margin
- 10.62%
- Net Profit Margin
- 8.09%
- EBITDA Margin
- 28.58%
- EBIT Margin
- 12.60%
Analyst Forecast
The average price target for Sanofi is MXN 1,111.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- MXN 1,111.67
- Price Target Upside
- 37.57% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 12.71%
- EPS Growth Forecast
- -37.01%
Scores
- Smart Score
- 6
- AI Score
- ―
